{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013396","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.225653+00:00","generated_at":"2026-05-20T01:57:52.779887+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Tevogen Bio doubles HQ leased space to 13,242 RSF; lease extended to Feb 2033","bullets":["Lease amendment doubles space from 6,708 to 13,242 rentable square feet on Building's 2nd floor.","Term extended seven years to February 28, 2033; annual base rent approx. $330,000 ($24.75/RSF).","Relocation from 4th floor to 2nd floor effective June 1, 2025; prior lease terminated.","Employees from Philadelphia R&D center to be relocated after its lease expires June 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013396","json":"https://secwatch.observer/filing/0001641172-25-013396.json","markdown":"https://secwatch.observer/filing/0001641172-25-013396.md","text":"https://secwatch.observer/filing/0001641172-25-013396.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225013396/0001641172-25-013396-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225013396/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:57:52.779887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}